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Summary 
During thymus development CD4 + CD8 + precursor cells differentiate into mature CD4 + and 
CD8 + T  cells expressing T  cell receptors (TCR) that recognize foreign antigens in association 
with major histocompatibility complex (MHC) class II or I molecules, respectively. Studies with 
TCR transgenic mice have shown that the accumulation of mature CD4 + and CD8 + thymo- 
cytes is strongly skewed by the MHC restriction specificity of the TCR, thus suggesting that 
commitment  of CD4 + CD8 + precursors to the CD4 or CD8 lineage is a direct consequence 
of TCR/MHC  interactions.  However,  we  show  here  that  CD4 +  cells  expressing  an  inap- 
propriate (MHC class I-specific) TCR appear transiently in the neonatal thymus of TCR trans- 
genic mice and can also be found in the periphery of adult TCR transgenic recombination-deficient 
SCID mice. These data argue that  the early stages of CD4 and CD8 lineage development in 
the thymus are (at least in part) controlled by homeostatic mechanisms independent  of appro- 
priate TCR/MHC  interactions. 
T 
he o~/~/TCR on mature CD4 + and CD8 § T  cells rec- 
ognizes foreign antigenic peptides in association with 
MHC class  II or I molecules, respectively. During  thymic 
development,  CD4 +  8-  and  CD4- 8 +  single-positive  (SP) 
cells arise from immature  (TCR-)  CD4-8-  precursors via 
a TCR + CD4 + 8 + double-positive (DP) intermediate  stage 
(1). Experiments with TCR transgenic mice have shown that 
the development of mature CD4 SP or CD8 SP cells is strongly 
influenced by the MHC restriction  specificity of the TCR 
(2). Thus, CD8 SP or CD4 SP cells accumulate preferentially 
in the thymus and periphery when the transgenic TCR is 
restricted by MHC class I or II molecules, respectively.  How- 
ever, the cellular and molecular basis of this phenomenon re- 
mains  obscure. 
Two models have been proposed to explain commitment 
of DP thymocytes to the CD4 or CD8 lineages. According 
to the instructional model (3), TCR engagement of MHC 
class I  or II molecules on DP thymocytes leads to specific 
downregulation of CD4 or CD8, respectively. Alternatively 
the stochastic model (4) predicts that CD4 or CD8 down- 
regulation occurs randomly among DP thymocytes, but that 
only those SP cells  expressing TCR of appropriate  MHC 
specificity are selected to survive.  Recent studies of T  cell 
development  in  double-transgenic  mice expressing  both  a 
MHC class 1-specific TCR and a constitutive CD8 gene were 
interpreted to favor the instructional model (5, 6). However, 
we show here that CD4 SP cells expressing an inappropriate 
(MHC class I-specific) TCR appear transiently in the neo- 
natal thymus of TCR transgenic mice and can also be found 
in  the  periphery  of adult  TCR  transgenic  recombination 
deficient SCID mice. These findings have important  impli- 
cations for the control of T  cell lineage commitment  and 
homeostasis during  development. 
Materials and Methods 
Mice.  Mice bearing transgenic TCR c~ (Vc~2-Jc~TA31) and 
TCR/3 (V/38.1 DJ/32.4) chains on a C57BL/6 (H-2  b) background 
were as described previously (7). In some experiments,  neonatal 
TCR  transgenic  mice were  injected  daily with  50/zg  protein 
A-purified  mAbs  directed  against  I-A  b (1D9; reference  8)  ac- 
cording to published procedures (9). Injected and control mice were 
killed after 9 d. TCR transgenic  SCID mice expressing H-2D  b 
were obtained by crossing C57BL/6 TCR transgenic mice with 
homozygous C.B-17 (H-2  a) SCID mice (IFFA-CREDO, L'Arbesle, 
France). TCR transgenic F1 mice were backcrossed to SCID and 
F2 progeny  were typed for transgenic TCR, H-2D  b, IgM,  and 
B220  in  peripheral  blood.  H-2Db-expressing  TCR  transgenic 
SCID mice with no detectable IgM § or B220 § cells were then 
further  analyzed at 6 wk of age. 
mAbs andFlow Cytometry.  Rat IgG mAbs directed against CD3 
(17A2), CD4 (GK-1.5), CD8 (53-6.7), Vc~2 (B20.1; reference 10), 
VB8 (KJ16), and heat-stable antigen (HSA; M1-69) were employed 
for staining as described (11). In some experiments rat IgM mAbs 
RL172.4 (anti-CD4) and 3.168.1 (anti-CDS) were used in the pres- 
ence of rabbit complement to deplete thymus or lymph node sus- 
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Volume 176  September  1992  903-907 pensions of CD4 + or CD8 + cells, respectively. Treated cells were 
routinely found to lack detectable CD4 (or CD8) expression. 
Double staining of thymus or lymph node was performed with 
PE-conjugated anti-CD4 and biotinylated anti-CD8 (revealed by 
avidin-TANDEM; Southern Biotechnology,  Birmingham, AL). For 
most triple-staining experiments, cells were first incubated with 
unconjugated mAbs against CD3, V~2, Vj38, or HSA (revealed 
by FITC-conjugated goat anti-rat Ig). After a blocking step with 
normal rat [g, the staining was completed for CD4 and CD8 as 
described above. In the case of CD4- or CD8-depleted cell suspen- 
sions, triple staining was performed with unconjugated anti-Vot2 
(revealed by FITC-conjugated goat anti-rat Ig), biotinylated anti- 
VB8 (revealed  by avidin-TANDEM), and PE-conjugated anti-CD4 
or anti-CD8. 
Data shown are representative of at least three mice tested indi- 
vidually. For all histograms gated on CD4 SP or CD8 SP cells, 
background controls were obtained by omitting the primary Ab. 
In the case of cytograms, regions were established such that nega- 
tive control staining fell within the lower left quadrant. 
Results and Discussion 
We examined the ontogeny of expression  of a transgenic 
TCR ot chain (c~r) and ~  chain (~T) derived from a CD8 
SP T cell done specific  for lymphocytic  choriomeningitis virus 
presented in the context of H-2D  b.  Positive selection of 
T  cells bearing this transgenic TCR and the concomitant 
skewing of adult thymocytes to the CD8 SP lineage had pre- 
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Figure  2.  Neonatal ontogeny of expression of transgenic TCK in 
C57BL/6  mice.  Thymus  and lymph  node  cells (harvested  at the indicated 
times) were triple stained  with mAbs against CD4, CDS, and either OtT 
or fT. Histograms  represent o~r or BT staining  gated on the CD4 SP or 
CD8 SP population. Percentages in each panel refer to cells in brightly 
staining peak (after subtraction of background staining). Negative con- 
trols overlapped the dull staining peaks seen in all CD4 SP samples. A 
nontransgenic C57BL/6 littermate  is inclnded  for comparison. The ki- 
netics of disappearance of the OCT and fit in CD4 SP thymocytes  varied 
among individual mice. 
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Figure 1.  Expression  of transgenic (H-2D~'-restricted) ot/f TCR by 
CD4 SP and CD8 SP thymocytes  from  neonatal  C57BL/6  mice. Neonatal 
(day  1) and day 10 total  thymoeytes  were  double  stained  with mAbs  against 
CD4 and CD8 (top). In addition,  CD8- and CD4-depleted  thymocyte  popu- 
lations were prepared and triple stained  with mAbs directed  against C~T, 
fiT, and either CD4 or CD8, respectively.  (Middle)  CD4 staining  pattern 
of CD8-depleted thymocytes.  (Bottom)  Expression of O/T and BT by the 
CD4 SP subset (gated as shown  in middle)  or the CD8 SP subset (gated 
similarly on CD8; data not shown). 
viously been shown to depend on the presence of the H-2D  b 
molecule (7, 12). As shown in Fig. 1, CD8 SP cells expressing 
the transgenic TCR were already present in increased numbers 
(20%)  in  the  thymus of young (10-d)  C57BL/6  (H-2  b) 
mice. Some CD4 SP thymocytes (~3%) were also present 
in these mice; however, these cells expressed predominantly 
endogenously  rearranged TCK chains. It is important to note 
that, in contrast to other MHC class I-restricted TCR trans- 
genic models (2), these CD4 SP thymocytes express endoge- 
nous TCR/3 (j3E) as well as TCR ot (c~E) chains (Fig. 1). 
Surprisingly, when we examined TCK expression in CD4 
SP thymocytes of neonatal (l-d) C57BL/6 TCK transgenic 
mice, we found that >80% of these cells expressed both O~T 
and BT at the same high levels as the CD8 SP thymocytes 
(Fig. 1). The proportion of aT+BT + CD4 SP cells declined 
rapidly so that by 10 d after birth CZT+/~T  + cells were vir- 
tually absent from the CD4 SP population, which contained 
approximately the same proportion of  ceils that stained singly 
with the Vot2- and VB8-specific antibodies (used to detect 
aT  or B'r) as  nontransgenic littermates (Fig.  2).  As  this 
aTBT combination is restricted by MHC class I (H-2D  b) in 
mature T  ceils, it seems likely that these neonatal CD4 SP 
thymocytes have made the transition from the DP to SP stage 
in the absence of an instructional signal given by appropriate 
TCR/MHC class II interaction. Since CD4 SP cells expressing 
the transgenic TCR were virtually undetectable in the pe- 
riphery and thymus of older mice,  we conclude that they 
were unable to survive and hence were rapidly replaced by 
CD4 SP cells expressing endogenously rearranged (presum- 
ably MHC class II-restricted) TCR. 
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Figure 3.  Detectable expression of transgenic TCIL on CD4 SP thymo- 
cytes is prolonged in mice treated postnatally  with and-MHC class  II mAbs. 
Thymocytes from control or anti-l-Ab-injected C57BL/6 TCR transgenic 
mice were prepared and analyzed for CD4, CDg, tXT, and 3T expression 
on day 9 as detailed in Fig. 1. CD8 SP thymocytes from both groups of 
mice homogeneously expressed c~T and 3T (not shown). 
To confirm this latter point, neonatal TCR transgenic mice 
were injected daily with purified mAb directed against I-AL 
As expected from previous studies with normal mice (9), this 
treatment selectively  reduced the percentage of CD4 SP thymo- 
cytes by 10-fold after 9 d (Fig. 3). Significantly, a large propor- 
tion (~-'50%) of surviving CD4 SP thymocytes from anti-l- 
Ab-treated mice coexpressed CXT and ~T, whereas no OIT+/3T  + 
CD4 SP thymocytes were found in uninjected controls (Fig. 
3). Taking into account the ~10-fold difference in cellularity 
between neonatal and day 9 thymus, these data indicate that 
CD4 SP thymocytes bearing MHC class I-restricted TCR 
continue to be produced at a relatively constant (low) rate 
during the early postnatal period but are diluted out by other 
CD4 SP cells (with endogenously rearranged TCR) that re- 
quire TCR/MHC class II interactions for their survival and/or 
expansion. 
In interpreting these data two important caveats must be 
considered. First, it could be argued (by analogy with other 
TCR transgenic models) that the C~T  +  BT  + CD4 SP thymo- 
cytes in fact also express ors at low levels and thus have been 
selected to the CD4 lineage as a result of interaction of c~E 
/~T TC1L with MHC class II. However, as noted above, our 
transgenic model is unique in that the surviving CD4 SP 
thymocytes in older H-2  b mice express only o~E and ~E and 
hence even oeE/~T TCR (which are detected transiently in 
lymph node on day 7; see Fig. 2) cannot be stably selected 
to the CD4 lineage. 
A second issue concerns the stage of development repre- 
sented by the C~T+I~T  + CD4 SP thymocytes. It is formally 
possible that these cells are an immature (i.e., pre-DP) subset, 
analogous to the CD3-  CD4 SP cells observed in low fre- 
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Figure 4.  Expression of transgenic TCR. and HSA by CD4 SP and CD8 
SP cells from recombination-deficient SCID mice. Thymocytes or lymph 
node cells from TCR transgenic SCID mice were double stained for CD4 
and CD8 (top). In addition, CD8-depleted thymocytes or lymph node cells 
were triple stained with mAbs against CD4,  OtT,  and •T.  (M/rid/e) Ex- 
pression of ST and ~T by the gated CD4 SP subset. (Bottom)  TCR trans- 
genic SCID lymph node cells were triple stained with mAbs against CD4, 
CDg, and either CD3, /3T, ~XT, or HSA. Histograms represent fluores- 
cence of the latter markers gated on either CD4 SP or CD8 SP subsets. 
The dotted lines indicate control staining. 
however, since kinetic studies of thymus regeneration after 
cortisone treatment in these TCR transgenic mice indicate 
that CD4 SP cells can only be detected after the appearance 
of DP thymocytes (11). Furthermore, light scatter analysis 
of early postnatal CXT  + ~T  +  CD4 SP thymocytes indicates that 
these cells are relatively small (Fig. 3; and data not shown), 
whereas CD3-CD4 SP thymocytes in normal mice are large 
cycling blasts  (13). 
Given the apparently nondirected transition from DP to 
CD4 SP thymocyte in the neonatal C57BL/6 TCR trans- 
genic mice, we decided to examine TCR expression in re- 
combination-deficient  SCID TCR transgenic mice, where the 
likelihood of selection on endogenously rearranged ot or B 
chains is further reduced. Surprisingly very few mature CD8 
SP thymocytes were seen in young (<4 wk) H-2Db-express - 
ing nonleaky SCID TCR transgenic mice, perhaps due to 
delayed functional maturity of the SCID thymic epithelium 
(14). However, in all 6-wk-old mice examined, we found the 
expected skewing to the CD8 SP lineage (15) in the thymus 
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thymocytes expressed both  ar  and 3T.  In blood,  lymph 
node (Fig.  4),  and spleen, however, there were substantial 
numbers of CD4 SP cells, all of which expressed 3r and at 
least 40% of which expressed OtT. The remaining CD4 SP 
otr-  cells,  which have also  been reported  in  other TCR 
transgenic SCID mice (15), presumably express orE, heavily 
sdected for by introduction of the transgenic TCK, despite 
the nonleakiness of the SCID mice in terms of B cell devel- 
opment. Alternatively, it cannot be excluded that these calls 
express a 3a" dimer as described in other experimental situa- 
tions (16,  17). 
The  CD3,  otT, and 3T  expressions were lower on the 
CD4 SP SCID lymph node calls than on the CD8 SP cells, 
and the CD4 SP cells expressed higher levels of heat-stable 
antigen (HSA) (Fig. 4), consistent with a less mature pheno- 
type (18). Thus, in a situation where endogenous TCK gene 
rearrangement is a very rare event, we found CD4 SP cells 
bearing a transgenic TCR c~ and 3  chain combination that 
is restricted by a MHC class I molecule. Interestingly, rare 
CD4  SP thymocytes and peripheral T  cells with a similar 
phenotype (TCK  ~~  HSA high) have been recently described 
in MHC class II-negative mice produced by gene disruption 
(19,  20). 
Several models of thymic differentiation would be consis- 
tent with the transient existence of CD4 SP thymocytes ex- 
pressing a TCR that cannot be positively selected by MHC 
class II. As discussed previously by Kobey et al.  (4,  5) and 
Borgulya et al.  (6),  such cells could arise stochastically if 
random downregulation of either CD4 or CD8 at the DP 
stage were followed by selective survival of SP cells expressing 
TCK of appropriate MHC specificity. One prediction of this 
model (at least in its simplest form) is that it should be pos- 
sible to rescue CD4 SP tbymocytes with inappropriate (MHC 
class I) TCR specificity b~, providing the cells with CD8. 
However, attempts to  directly confirm this hypothesis by 
crossing TCK transgenic mice with other transgenic mice 
expressing CD8 constitutively have thus far not been suc- 
cessful (5, 6). Alternatively, it could be postulated that DP 
thymocytes are already precommitted to either the CD4 or 
CD8 SP lineages at an early stage (i.e., before TCR engage- 
ment). In this case, survival and further maturation of these 
committed DP precursor cells along the chosen SP lineage 
might normally depend (at least in part) upon positive fig- 
naling via appropriate TCK/MHC and/or CD4-CD8/MHC 
interactions.  In situations where there are no (or few) DP 
thymocytes fulfiUing these criteria, homeostatic control mech- 
anisms may nevertheless guarantee the production of a limited 
number of SP thymocytes with inappropriate TCR specificity 
for MHC, as is the case in the SCID and neonatal TCK trans- 
genic mice described here. 
Finally,  it should be emphasized that the data presented 
here pertain only to early stages  of T  cell development in 
the thymus and hence do not in any way contradict the con- 
cept that positive selection of functional T cells is ultimately 
dependent upon appropriate TCR/MHC interactions. Indeed, 
the rapid disappearance of CD4 SP thymocytes bearing MHC 
class I-restricted transgenic TCR in the neonatal thymus and 
their replacement by other CD4 SP thymocytes expressing 
endogenous MHC class II-restricted TCK is entirely consis- 
tent with positive selection models. 
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